{"id":30311,"date":"2025-01-20T10:59:32","date_gmt":"2025-01-20T09:59:32","guid":{"rendered":"https:\/\/ggba.swiss\/?p=30311"},"modified":"2025-01-20T10:59:36","modified_gmt":"2025-01-20T09:59:36","slug":"medtech-aspivix-secures-eur-1-95-million-in-crowdfunding","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/","title":{"rendered":"Medtech Aspivix secures EUR 1.95 million in crowdfunding"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.aspivix.com\/\">Aspivix<\/a>, which is headquartered in the canton of Vaud, is revolutionizing gynecological practices with Carevix\u2122, a device designed to replace traditional Pozzi forceps. The device uses gentle suction to stabilize the cervix, significantly reducing pain, bleeding, and stress associated with gynecological procedures. Carevix\u2122 is FDA-cleared for the U.S. market, CE-marked for the EU, and approved in the UK and Brazil. Already in use across a network of clinics in the U.S., the device is poised for broader adoption.<\/p>\n\n\n\n<p>The journey began with a conversation between brothers\u2014Julien Finci, an engineer, and David Finci, a gynecologist\u2014who identified the discomfort caused by Pozzi forceps as a critical area for improvement. With the expertise of co-founder Mathieu Horras, Carevix\u2122 was developed as a patient-friendly alternative. Protected by several patents, the device is a game-changer for gynecological care, combining simplicity with cutting-edge technology.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Powered by Swiss Innovation<\/h4>\n\n\n\n<p>Aspivix\u2019s growth is supported by the vibrant Western Switzerland \u201cHealth Valley\u201d ecosystem. Partnerships with the University Hospital of Lausanne (<a href=\"https:\/\/www.lausanneuniversityhospital.com\/home\">CHUV<\/a>), <a href=\"https:\/\/www.epfl.ch\/en\/\">EPFL<\/a>, and <a href=\"https:\/\/heig-vd.ch\/\">HEIG-VD<\/a> have played a crucial role in product development and clinical validation. Backed by initiatives such as Innosuisse and Innovaud, the company has attracted strategic collaborations, including a partnership with Bayer in 2024.<\/p>\n\n\n\n<p>The company\u2019s achievements have garnered international recognition, with <em>Time<\/em> magazine naming Carevix\u2122 among the 200 best inventions of 2024. The crowdfunding campaign will enable Aspivix to scale production and expand its presence in key markets. Aspivix&#8217;s crowdfunding initiative has attracted 85 investors to date, demonstrating broad support for its mission to improve women&#8217;s healthcare. As the campaign progresses, Aspivix remains committed to leveraging its innovative technology to bring comfort and dignity to patients worldwide.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Start-up Aspivix has raised EUR 1.95 million through a crowdfunding campaign to advance the commercialization of its innovative gynecological device, Carevix\u2122. The campaign, hosted on the Capital Cell platform, aims to reach a target of EUR 2.15 million by 15 March 2025.<\/p>\n","protected":false},"author":6,"featured_media":30312,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[894,890,963,926],"class_list":["post-30311","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-financing","tag-healthcare","tag-medical-devices","tag-medtech"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medtech Aspivix secures EUR 1.95 million in crowdfunding | GGBa<\/title>\n<meta name=\"description\" content=\"Aspivix has raised EUR 1.95 million through a crowdfunding campaign to advance the commercialization of its innovative gynecological device.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medtech Aspivix secures EUR 1.95 million in crowdfunding | GGBa\" \/>\n<meta property=\"og:description\" content=\"Aspivix has raised EUR 1.95 million through a crowdfunding campaign to advance the commercialization of its innovative gynecological device.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-20T09:59:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-20T09:59:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Medtech Aspivix secures EUR 1.95 million in crowdfunding\",\"datePublished\":\"2025-01-20T09:59:32+00:00\",\"dateModified\":\"2025-01-20T09:59:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/\"},\"wordCount\":282,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg\",\"keywords\":[\"Financing\",\"Healthcare\",\"Medical Devices\",\"Medtech\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/\",\"url\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/\",\"name\":\"Medtech Aspivix secures EUR 1.95 million in crowdfunding | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg\",\"datePublished\":\"2025-01-20T09:59:32+00:00\",\"dateModified\":\"2025-01-20T09:59:36+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Aspivix has raised EUR 1.95 million through a crowdfunding campaign to advance the commercialization of its innovative gynecological device.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"Aspivix's Carevix\u2122 device offers a transformative alternative to traditional gynecological tools, reducing patient discomfort while advancing the field of women's healthcare worldwide. | \u00a9 Aspivix\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medtech Aspivix secures EUR 1.95 million in crowdfunding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medtech Aspivix secures EUR 1.95 million in crowdfunding | GGBa","description":"Aspivix has raised EUR 1.95 million through a crowdfunding campaign to advance the commercialization of its innovative gynecological device.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/","og_locale":"en_US","og_type":"article","og_title":"Medtech Aspivix secures EUR 1.95 million in crowdfunding | GGBa","og_description":"Aspivix has raised EUR 1.95 million through a crowdfunding campaign to advance the commercialization of its innovative gynecological device.","og_url":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-01-20T09:59:32+00:00","article_modified_time":"2025-01-20T09:59:36+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Medtech Aspivix secures EUR 1.95 million in crowdfunding","datePublished":"2025-01-20T09:59:32+00:00","dateModified":"2025-01-20T09:59:36+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/"},"wordCount":282,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg","keywords":["Financing","Healthcare","Medical Devices","Medtech"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/","url":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/","name":"Medtech Aspivix secures EUR 1.95 million in crowdfunding | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg","datePublished":"2025-01-20T09:59:32+00:00","dateModified":"2025-01-20T09:59:36+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Aspivix has raised EUR 1.95 million through a crowdfunding campaign to advance the commercialization of its innovative gynecological device.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg","width":1180,"height":811,"caption":"Aspivix's Carevix\u2122 device offers a transformative alternative to traditional gynecological tools, reducing patient discomfort while advancing the field of women's healthcare worldwide. | \u00a9 Aspivix"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Medtech Aspivix secures EUR 1.95 million in crowdfunding"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/30311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=30311"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/30311\/revisions"}],"predecessor-version":[{"id":30315,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/30311\/revisions\/30315"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/30312"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=30311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=30311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=30311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}